When Michele Hall began experiencing alarming memory problems, her doctors initially suggested that she was going through menopause or perhaps experiencing unusual levels of…
Drugmakers Eisai and Biogen just announced the success of their latest Phase 3 trial for the Alzheimer’s anti-amyloid drug lecanemab, setting the stage for…
The pursuit of a cure for Alzheimer’s disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies. In…
University of Birmingham neurology fellow and dreams researcher Abidemi Otaiku discusses his new study on nightmares as a possible predictor of cognitive decline or…
One of the largest genetic studies to date revealed extensive genetic links between Alzheimer’s and gut disorders. Cholesterol was a major factor in both….
It may be common knowledge that high-sugar, high-fat junk food (think: fried foods, milkshakes, pastries, cakes and cookies) aren’t good for your waistline, but…
The earlier someone receives an Alzheimer’s diagnosis, the more time they have to plan with their family and doctors. It means that the person…
Hormone replacement therapy (HRT) for estrogen — the use of pills, topical gels, and other applications to supplement estrogen production — is used to treat…
Better Alzheimer’s treatments are going to require better models of Alzheimer’s brains in the lab, researchers say. Psychology researcher Étienne Aumont at the University…
According to an Eisai press release, the U.S. Food and Drug Administration has now granted priority review to a new anti-amyloid drug by Biogen…
Neurology and psychiatry professor Christopher Filley at the University of Colorado Anschutz Medical Campus shares insights from new research on brain’s gray matter and…
Vaccines are considered one of the greatest innovations in medical history. Immunizations help train the body’s immune system to recognize and respond to a…
This Alzheimer’s drug has already been approved for use in China. The clinical trials that could lead to approval in the U.S. have just…
UPDATE: 3 March 2024, 8:30 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Brain cells from people with Alzheimer’s have a unique pattern of mutations, which may help explain why the cells begin to die. The genetic…